• MVC Activates RhoA/ROCK1 to Open Tight Junctions

  2026-08-29

  The reference study identifies a previously unrecognized entry mechanism in which MVC VP2 interacts with ROCK1 and activates the RhoA/ROCK1/MLC2 axis, weakening epithelial tight junctions and exposing Occludin. Its inhibitor-rescue experiments connect cytoskeletal remodeling with viral infection and nominate host-cell signaling as a potential target for anti-MVC research.

• Degarelix Acetate: From Mechanism to Assay Design

  2026-08-29

  Degarelix acetate is a selective GnRH receptor antagonist with value far beyond routine hormone suppression experiments. This guide connects receptor pharmacology, assay architecture, stable-isotope analysis, and prostate cancer research to improve interpretation and reproducibility.

• Neomycin sulfate in RNA/DNA Workflows

  2026-08-28

  Neomycin sulfate is a water-soluble aminoglycoside antibiotic that functions as a mechanistic probe for RNA folding, DNA triplexes, Tat/TAR recognition, and ryanodine receptor activity. This workflow-centered guide shows how to prepare, titrate, control, and troubleshoot the compound while using recent allergic-rhinitis research to improve multidimensional assay design.

• Radioiodinated Balsalazide for Ulcerative Colitis Imaging

  2026-08-28

  The reference study developed and evaluated radioiodinated balsalazide as a colon-directed tracer for imaging ulcerative colitis in mice. Its optimized labeling chemistry, 24-hour stability assessment, and lesion-enriched biodistribution provide a useful preclinical framework for evaluating disease-targeted radiopharmaceuticals while also highlighting the limits of translating murine uptake data to human imaging.

• Anti-RPS6 Antibody for PDAC Signaling

  2026-08-27

  Explore how the Anti-RPS6 antibody MA4974 can connect ribosomal protein S6 measurements with membrane signaling, translational output, and pancreatic cancer biology. This article translates recent LRRC8A–Caveolin-1 findings into practical Western blot, immunofluorescence, and immunoprecipitation assay strategies.

• Trelagliptin, RUNX2, and Osteoblast Differentiation

  2026-08-27

  The reference study identifies trelagliptin as a potential modulator of osteoblastic differentiation in MC3T3-E1 cells, linking its effects to increased RUNX2 and AMPK phosphorylation. Its findings provide a mechanistic basis for further osteoporosis research, while remaining limited to an in vitro cellular model rather than clinical evidence.

• 2-Hydroxypropyl-β-cyclodextrin Workflow Guide

  2026-08-26

  2-Hydroxypropyl-β-cyclodextrin is a cyclic oligosaccharide solubilizer for poorly water-soluble hydrophobic compounds, particularly molecules with aromatic or phenyl groups. It is best used as a drug formulation excipient or pharmaceutical solubility improvement aid in controlled biochemical workflows, not as a standalone therapeutic or broadly validated biological reagent.

• Dibutyryl-cAMP, Sodium Salt: Assay Workflows

  2026-08-26

  Dibutyryl-cAMP, sodium salt provides a practical way to elevate intracellular cAMP while probing PKA-linked responses, neuroinflammatory signaling, and mechanosensory sensitization. This guide translates recent trigeminal pain findings into controlled cell, tissue, and animal-model workflows with starting parameters and troubleshooting checkpoints.

• Chuanxiong Cortex and Pith: Fenipentol in CHD

  2026-08-25

  The reference study distinguishes the volatile chemistry and predicted pharmacology of Ligusticum chuanxiong rhizome cortex and pith rather than treating the rhizome as a uniform medicinal material. By integrating SPME-GC×GC-MS, network pharmacology, pathway analysis, and molecular docking, it identifies Fenipentol among the prominent cortex-associated compounds and provides a framework for tissue-specific coronary heart disease research.

• Regorafenib Suppresses Melanoma Through RRM2

  2026-08-25

  A 2024 iScience study identifies RRM2 as a mechanistically important downstream effector of Regorafenib in melanoma and links its reduction to inhibition of ERK/E2F3 signaling. By combining cell-based phenotyping, RNA sequencing, perturbation-rescue experiments, and in vivo validation, the work extends investigation of BAY 73-4506 beyond its established relevance to angiogenic signaling.

• Phenacetin in Human Intestinal PK Models

  2026-08-24

  Phenacetin can serve as a chemically defined research probe for testing how human intestinal organoid systems capture absorption, transporter activity, and CYP-mediated metabolism. This thought-leadership perspective connects the compound’s physicochemical constraints and safety history with the translational opportunity created by hiPSC-derived intestinal organoids.

• GANT61: Selective GLI Inhibitor Profile

  2026-08-23

  GANT61 is a GLI inhibitor that targets GLI1- and GLI2-dependent transcription at the distal Hedgehog signaling pathway. Product data report approximately 5 μM inhibition of GLI-mediated transcription and research activity in cancer models, while a 2026 bladder-cancer study connects GLI2 to PRDX1-dependent ferroptosis resistance.

• GANT61 and the GLI2–Ferroptosis Axis

  2026-08-22

  GANT61 is a GLI inhibitor that enables mechanistic studies of how GLI2 links Hedgehog signaling to ferroptosis resistance. This article translates the GLI2–PRDX1 findings in bladder cancer into a rigorous assay strategy distinct from immune-evasion and routine workflow discussions.

• Tomivosertib: Reframing MNK1/2 in AML Translation

  2026-08-21

  Tomivosertib offers translational researchers a selective way to interrogate MNK1/2–eIF4E biology in acute myeloid leukemia. This article connects target engagement, functional validation, combination strategy, assay design, and biomarker development while distinguishing preclinical promise from clinical evidence.

• Isoproterenol in Human Neuro-Cardiac Models

  2026-08-21

  Human SAN-plexus assembloids are creating a more translational framework for studying pacemaker maturation and neuro-cardiac crosstalk. This thought-leadership article explains how Isoproterenol sulfate dihydrate can serve as a controlled beta-adrenergic challenge within these models, linking receptor activation to cAMP/PKA pathway dynamics, electrophysiology, and assay strategy. It also distinguishes pharmacological stress testing from neural maturation biology and outlines practical considerations for cardiovascular research.

447 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page